HR 5316 — Drug Shortage Compounding Patient Access Act of 2025
Congress 119
Latest action: — Referred to the House Committee on Energy and Commerce.
Sponsors
- Owens, Burgess (R, UT-4) — cosponsor
- Harris, Andy (R, MD-1) — cosponsor
Lobbied by (2)
LDA filings that named this bill in their activity descriptions. The lobbying firm (registrant) is paid by the client to lobby on this and related issues.
| Filing | Period | Registrant (lobbying firm) | Client | Income | Matched |
|---|---|---|---|---|---|
| 1st Quarter - Report | 2026 first_quarter | HANCE SCARBOROUGH | ALLIANCE FOR PHARMACY COMPOUNDING | $50,000 | HR 5316 |
| 1st Quarter - Report | 2026 first_quarter | FORBES-TATE | ELI LILLY AND COMPANY FKA LILLY USA, LLC | $50,000 | H.R. 5316 |
Action timeline
- · H11100 — Referred to the House Committee on Energy and Commerce.
- · Intro-H — Introduced in House
- · 1000 — Introduced in House
Text versions
- Introduced in House · 2025-09-11 — open
Connected on the graph
Inbound (4)
| date | from | type | amount | role | source |
|---|---|---|---|---|---|
| — | Owens, Burgess | cosponsor_of_bill | — | cosponsor | sponsorship |
| — | Harris, Andy | cosponsor_of_bill | — | cosponsor | sponsorship |
| 2026-01-01 | ELI LILLY AND COMPANY FKA LILLY USA, LLC | lobbies_on_bill | — | H.R. 5316 | lobbying_bill_mention |
| 2026-01-01 | ALLIANCE FOR PHARMACY COMPOUNDING | lobbies_on_bill | — | HR 5316 | lobbying_bill_mention |
Outbound (1)
| date | type | to | amount | role | source |
|---|---|---|---|---|---|
| 2025-01-03 | referred_to_committee | House Energy and Commerce Committee | — | congress-committee |
Who matters
Members ranked by combined influence on this bill: role (sponsor 5 / cosponsor 1), capped speech count from the Congressional Record, and recorded-vote engagement.
| # | Member | Role | Speeches | Voted | Score |
|---|---|---|---|---|---|
| 1 | Harris, Andy (R, house MD-1) | cosponsor | 0 | — | 1 |
| 2 | Owens, Burgess (R, house UT-4) | cosponsor | 0 | — | 1 |
Who's influencing them
Orgs ranked by combined money flow on this bill: LDA filings citing the bill + individual contributions in cycle 2026from donors whose employer matches the org name (Schedule A) to any principal committee in the "who matters" list above.
| # | Org | LDA filings | LDA spend | Donor employees | Employee donations | Total |
|---|---|---|---|---|---|---|
| 1 | ELI LILLY AND COMPANY FKA LILLY USA, LLC | 1 | $50,000 | 0 | $0 | $50,000 |
| 2 | ALLIANCE FOR PHARMACY COMPOUNDING | 1 | $50,000 | 0 | $0 | $50,000 |
| 3 | none | 0 | $0 | 58 | $13,432 | $13,432 |
| 4 | story partners | 0 | $0 | 1 | $7,000 | $7,000 |
| 5 | verano | 0 | $0 | 1 | $6,500 | $6,500 |
| 6 | continental realty corporation | 0 | $0 | 1 | $6,000 | $6,000 |
| 7 | jushi holdings | 0 | $0 | 2 | $5,000 | $5,000 |
| 8 | self employed | 0 | $0 | 4 | $4,810 | $4,810 |
| 9 | kelly & associates insurance group, in | 0 | $0 | 1 | $2,000 | $2,000 |
| 10 | kelly benefits | 0 | $0 | 2 | $2,000 | $2,000 |
| 11 | buckeye relief | 0 | $0 | 1 | $2,000 | $2,000 |
| 12 | umms | 0 | $0 | 1 | $2,000 | $2,000 |
| 13 | jushi holding | 0 | $0 | 1 | $2,000 | $2,000 |
| 14 | retired | 0 | $0 | 48 | $1,776 | $1,776 |
| 15 | nutramax laboratories, inc. | 0 | $0 | 1 | $1,000 | $1,000 |
| 16 | alterwood health | 0 | $0 | 1 | $1,000 | $1,000 |
| 17 | kelly & assoc. insurance | 0 | $0 | 1 | $1,000 | $1,000 |
| 18 | mackenzie ventures llc | 0 | $0 | 1 | $1,000 | $1,000 |
| 19 | nutramax labs | 0 | $0 | 1 | $1,000 | $1,000 |
| 20 | grasmick lumber | 0 | $0 | 1 | $1,000 | $1,000 |
| 21 | goetze's candy co | 0 | $0 | 1 | $1,000 | $1,000 |
| 22 | mhs | 0 | $0 | 1 | $500 | $500 |
| 23 | farragut partners | 0 | $0 | 1 | $500 | $500 |
| 24 | ellin & tucker | 0 | $0 | 1 | $500 | $500 |
| 25 | brg | 0 | $0 | 1 | $500 | $500 |
Predicted vote
Aggregated from: actual roll-call votes (when present) → sponsor → cosponsor → party median (predicts YES when ≥25% of the caucus sponsored/cosponsored). Each row labels its confidence tier so you can see why a position was predicted.
2 predicted yes (0%) · 266 predicted no (49%) · 275 unknown (51%)
By party: · R: 2 yes / 0 no / 275 unknown · D: 0 yes / 263 no · I: 0 yes / 3 no
2 high-confidence positions (voted + sponsor + cosponsor)
- Harris, Andy (R · house · MD-1) · cosponsor
- Owens, Burgess (R · house · UT-4) · cosponsor
Activity
Every typed-graph event involving this entity, newest first. Each row is one edge in the influence graph; click the date to jump to its provenance.
- 2026-05-17 · cosponsored by Owens, Burgess (cosponsor) · sponsorship
- 2026-05-17 · cosponsored by Harris, Andy (cosponsor) · sponsorship
- 2026-01-01 · lobbied on by ALLIANCE FOR PHARMACY COMPOUNDING (hr 5316) · lobbying_bill_mention
- 2026-01-01 · lobbied on by ELI LILLY AND COMPANY FKA LILLY USA, LLC (h.r. 5316) · lobbying_bill_mention
- 2025-01-03 · was referred to House Energy and Commerce Committee · congress-committee